Streetbeat News

Products Services

AAPL

INTC

During Apple's Q4 earnings call, CEO Tim Cook reaffirmed the company's commitment to using internal silicon for their products, stating that the transition to in-house silicon production has been economically profitable and enabled the creation of new products. This comes after Apple launched its latest proprietary chips, the M3, M3 Pro, and M3 Max, and completed its transition from Intel chips in 2023.

Portfolio Pulse from Ananya Gairola

November 03, 2023 | 11:23 am

MNTS

Momentus has announced the completion of vibration testing for its Vigoride Orbital Service Vehicle, which is scheduled to launch on SpaceX's Transporter-10 mission no earlier than March 2024.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:19 am

GAME

GameSquare reported that Q3 2023 generated 7.6 billion hours watched across all platforms. The company also noted that streaming numbers are stabilizing, with hours watched almost the same in Q3 2020.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:17 am

CHWY

FIGS

FIGS, Inc reported Q3 FY23 sales growth of 11% YoY to $142.36 million, beating the analyst consensus estimate. The revenue rise was driven by increased orders from existing and new customers. Gross profit rose 7.2% to $97.4 million. Active customers increased 19.6% to 2.6 million. The company held $232 million in cash and equivalents. FIGS has appointed Mario Marte, former CFO of Chewy, Inc, to its Board of Directors. FIGS also announced the opening of its first permanent physical retail space. The company raised FY23 net revenue growth to about 8.5% and adjusted EBITDA margin to about 14%.

Portfolio Pulse from Shivani Kumaresan

November 03, 2023 | 11:17 am

HOWL

Werewolf Therapeutics has presented preliminary data from its Phase 1/1b clinical trial for WTX-124 at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting. The data establishes proof of mechanism for WTX-124.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:13 am

CSTL

Castle Biosciences has announced early exploratory study data for the potential development of a complementary test to accompany DecisionDx-UM, which could aid in early detection of uveal melanomas.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:12 am

PSTV

Plus Therapeutics has been granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda, a drug for breast cancer treatment with leptomeningeal metastases.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:05 am

TSLA

Elon Musk's AI venture, xAI, is set to release its first AI model to a select group. This comes a day after Musk, the CEO of Tesla Inc. (NASDAQ:TSLA), reiterated that AI poses an existential threat to humanity. The launch of xAI is seen as critical to understand Musk's direction for AI.

Portfolio Pulse from Rounak Jain

November 03, 2023 | 10:48 am

AIXI

Xiao-I Corporation (NASDAQ:AIXI), a leading cognitive artificial intelligence enterprise in China, has announced the launch of Hua Zang Universal Large Language Model Ecosystem. This tool will enable businesses to tailor and deploy AI-empowered services and products with precision. The platform is designed to be adaptable to various industries, providing a solution for businesses looking to harness the potential of AI.

Portfolio Pulse from Charles Gross

November 03, 2023 | 10:38 am

IMMP

MRK

Immutep has announced new biomarker data from the TACTI-002/KEYNOTE-798 Phase 2 trial of Eftilagimod Alpha combined with Merck's Keytruda as a first-line treatment for unresectable or metastatic non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 10:11 am